Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dihydroxyundecyl Resorcylic Acid Lactone
2. P 1496
3. P-1496
4. P1496
5. Ralone
6. Xeranol
7. Zearalanol
8. Zearanol
9. Zeranol
1. 55331-29-8
2. Frideron
3. Zearanol
4. Ralone
5. Zeranol (racemic)
6. P 1496
7. 8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one
8. 7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1h-2-benzoxacyclotetradecin-1-one
9. Alpha Zearalanol
10. Ralabol (tn)
11. Zeranol (usan/inn)
12. Zeranol [usan:inn:ban]
13. Xeranol
14. Zerano
15. 7,15,17-trihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one
16. Zeranol (4)
17. A-zearalanol
18. Thfes(hm)
19. 6-(6,10-dihydroxyundecyl)-beta-resorcylic Acid, Mu-lactone
20. Zeranol (mixture Of Isomers)
21. Zeranol, Ban, Inn, Usan
22. Schembl2602612
23. Dtxsid70860370
24. Bdbm235684
25. Hms3370d21
26. Hms3370f15
27. Hms3393f11
28. (3s,7x)-3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-1h-2-benzoxacyclotetradecin-1-one
29. 1h-2-benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, [3s-(3r*,7s*)]-
30. Zeranol 100 Microg/ml In Methanol
31. Akos001029828
32. Dihydroxyundecyl Resorcylic Acid Lactone
33. Ncgc00184708-02
34. Ncgc00184708-04
35. 1h-2-benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-
36. Ac-14977
37. Db-050911
38. Ft-0639791
39. Ab01209732-01
40. Ab01209732-04
41. Z56763036
42. Zeranol (mixture Of Isomers) 100 Microg/ml In Acetonitrile
43. 6-(6,10-dihydroxyundecyl)-.beta.-resorcylic Acid, .mu.-lactone
44. (6x,10s)-6-(6,10-dihydroxyundecyl)-.beta.-resorcylic Acid .mu.-lactone
45. Rac-ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconiumdichloride
46. 1h-2-benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3s,7r)-(+)-
47. 1h-2-benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3s,7x)-
48. 7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1h-2-benzoxacyclotetradecin-1-one-, (3s-(3r*,7s*))-
Molecular Weight | 322.4 g/mol |
---|---|
Molecular Formula | C18H26O5 |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 322.17802393 g/mol |
Monoisotopic Mass | 322.17802393 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 372 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Estrogens, Non-Steroidal
Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22441
Submission : 2009-01-21
Status : Inactive
Type : II
NDC Package Code : 58623-0135
Start Marketing Date : 2019-09-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5724
Submission : 2001-06-08
Status : Inactive
Type : II
VMF Number : 5751
Submission : 2002-10-28
Status : Active
Type : II
Regulatory Info : OTC
Registration Country : Canada
Brand Name : RALGRO
Dosage Form : IMPLANT
Dosage Strength : 36MG/DOSE
Packaging : 10 - 24 DOSE
Approval Date :
Application Number : 2137607
Regulatory Info : OTC
Registration Country : Canada
Related Excipient Companies
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Topical
Excipient Details : Boric acid is used as an antimicrobial preservative in topical formulations such as creams and ointments.
Pharmacopoeia Ref : EP
Technical Specs : 99.9 % Boric Acid (H3BO3)
Ingredient(s) : Boric Acid Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Brand Name : Microlose™ M60 P60
Application : Fillers, Diluents & Binders
Excipient Details : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.
Pharmacopoeia Ref : In-house
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Lactose Monohydrate
Application : Parenteral
Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.
Dosage Form : Tablet
Grade : Not Available
Brand Name : Magnesium Stearate
Application : Lubricants & Glidants
Excipient Details : Lubricants, Anti-adhesive, Glidant
Excipients by Applications
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?